204 related articles for article (PubMed ID: 8096088)
1. SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases.
Feng GS; Hui CC; Pawson T
Science; 1993 Mar; 259(5101):1607-11. PubMed ID: 8096088
[TBL] [Abstract][Full Text] [Related]
2. Two axes in platelet-derived growth factor signaling: tyrosine phosphorylation and reactive oxygen species.
Kang SW
Cell Mol Life Sci; 2007 Mar; 64(5):533-41. PubMed ID: 17221164
[TBL] [Abstract][Full Text] [Related]
3. Receptor-binding, tyrosine phosphorylation and chromosome localization of the mouse SH2-containing phosphotyrosine phosphatase Syp.
Feng GS; Shen R; Heng HH; Tsui LC; Kazlauskas A; Pawson T
Oncogene; 1994 Jun; 9(6):1545-50. PubMed ID: 8183548
[TBL] [Abstract][Full Text] [Related]
4. KRAS: Biology, Inhibition, and Mechanisms of Inhibitor Resistance.
Ash LJ; Busia-Bourdain O; Okpattah D; Kamel A; Liberchuk A; Wolfe AL
Curr Oncol; 2024 Apr; 31(4):2024-2046. PubMed ID: 38668053
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine phosphatase SHP2 aggravates tumor progression and glycolysis by dephosphorylating PKM2 in gastric cancer.
Wang P; Han Y; Pan W; Du J; Zuo D; Ba Y; Zhang H
MedComm (2020); 2024 Apr; 5(4):e527. PubMed ID: 38576457
[TBL] [Abstract][Full Text] [Related]
6.
Yang Y; Yan Z; Xie Q; Wang Y; Liu Z; Lei M
Aging (Albany NY); 2024 Apr; 16(7):6334-6347. PubMed ID: 38575308
[TBL] [Abstract][Full Text] [Related]
7. Innate immune signal transduction pathways to fungal infection: Components and regulation.
Chen T; Gao C
Cell Insight; 2024 Jun; 3(3):100154. PubMed ID: 38464417
[No Abstract] [Full Text] [Related]
8. Binding Free Energy Calculation Based on the Fragment Molecular Orbital Method and Its Application in Designing Novel SHP-2 Allosteric Inhibitors.
Yuan Z; Chen X; Fan S; Chang L; Chu L; Zhang Y; Wang J; Li S; Xie J; Hu J; Miao R; Zhu L; Zhao Z; Li H; Li S
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203841
[TBL] [Abstract][Full Text] [Related]
9. Consideration of SHP-1 as a Molecular Target for Tumor Therapy.
Lim S; Lee KW; Kim JY; Kim KD
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203502
[TBL] [Abstract][Full Text] [Related]
10. Targeting SHP2 with an Active Site Inhibitor Blocks Signaling and Breast Cancer Cell Phenotypes.
Lade DM; Agazie YM
ACS Bio Med Chem Au; 2023 Oct; 3(5):418-428. PubMed ID: 37876496
[TBL] [Abstract][Full Text] [Related]
11. Setting sail: Maneuvering SHP2 activity and its effects in cancer.
Welsh CL; Allen S; Madan LK
Adv Cancer Res; 2023; 160():17-60. PubMed ID: 37704288
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of machine learning models for the prediction of SH-2 containing protein tyrosine phosphatase 2 inhibitors.
Adhikari N; Ayyannan SR
Mol Divers; 2023 Aug; ():. PubMed ID: 37552436
[TBL] [Abstract][Full Text] [Related]
13. Potent molecular-targeted therapies for advanced esophageal squamous cell carcinoma.
Ooki A; Osumi H; Chin K; Watanabe M; Yamaguchi K
Ther Adv Med Oncol; 2023; 15():17588359221138377. PubMed ID: 36872946
[TBL] [Abstract][Full Text] [Related]
14. Modeling (not so) rare developmental disorders associated with mutations in the protein-tyrosine phosphatase SHP2.
Solman M; Woutersen DTJ; den Hertog J
Front Cell Dev Biol; 2022; 10():1046415. PubMed ID: 36407105
[TBL] [Abstract][Full Text] [Related]
15. SHP2 regulates adipose maintenance and adipocyte-pancreatic cancer cell crosstalk via PDHA1.
Olou AA; Ambrose J; Jack JL; Walsh M; Ruckert MT; Eades AE; Bye BA; Dandawate P; VanSaun MN
J Cell Commun Signal; 2023 Sep; 17(3):575-590. PubMed ID: 36074246
[TBL] [Abstract][Full Text] [Related]
16. Targeting macrophagic SHP2 for ameliorating osteoarthritis
Sun Z; Liu Q; Lv Z; Li J; Xu X; Sun H; Wang M; Sun K; Shi T; Liu Z; Tan G; Yan W; Wu R; Yang YX; Ikegawa S; Jiang Q; Sun Y; Shi D
Acta Pharm Sin B; 2022 Jul; 12(7):3073-3084. PubMed ID: 35865095
[TBL] [Abstract][Full Text] [Related]
17. A pan-cancer analysis confirms PTPN11's potential as a prognostic and immunological biomarker.
Cao Y; Duan H; Su A; Xu L; Lai B
Aging (Albany NY); 2022 Jul; 14(13):5590-5610. PubMed ID: 35802774
[TBL] [Abstract][Full Text] [Related]
18. Recent insights into the pathogeneses and therapeutic targets of liver diseases: Summary of the 4th Chinese American Liver Society/Society of Chinese Bioscientists in America Hepatology Division Symposium in 2021.
Ding WX; Wang H; Zhang Y
Liver Res; 2022 Mar; 6(1):50-57. PubMed ID: 35747395
[TBL] [Abstract][Full Text] [Related]
19. Targeting protein phosphatases for the treatment of inflammation-related diseases: From signaling to therapy.
Pan J; Zhou L; Zhang C; Xu Q; Sun Y
Signal Transduct Target Ther; 2022 Jun; 7(1):177. PubMed ID: 35665742
[TBL] [Abstract][Full Text] [Related]
20. Intramolecular Interaction with the E6 Region Stabilizes the Closed Conformation of the N-SH2 Domain and Concurs with the Self-Inhibitory Docking in Downregulating the Activity of the SHP2 Tyrosine Phosphatase: A Molecular Dynamics Study.
Bellacchio E
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
